CD39/adenosine pathway is involved in AIDS progression.

HIV-1 infection is characterized by a chronic activation of the immune system and suppressed function of T lymphocytes. Regulatory CD4+ CD25(high) FoxP3+CD127(low) T cells (Treg) play a key role in both conditions. Here, we show that HIV-1 positive patients have a significant increase of Treg-associ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maria Nikolova, Matthieu Carriere, Mohammad-Ali Jenabian, Sophie Limou, Mehwish Younas, Ayrin Kök, Sophie Huë, Nabila Seddiki, Anne Hulin, Olivier Delaneau, Hanneke Schuitemaker, Joshua T Herbeck, James I Mullins, Maria Muhtarova, Armand Bensussan, Jean-François Zagury, Jean-Daniel Lelievre, Yves Lévy
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
Acceso en línea:https://doaj.org/article/6978a6a1af86471db9fda97b11c647d1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6978a6a1af86471db9fda97b11c647d1
record_format dspace
spelling oai:doaj.org-article:6978a6a1af86471db9fda97b11c647d12021-11-18T06:03:14ZCD39/adenosine pathway is involved in AIDS progression.1553-73661553-737410.1371/journal.ppat.1002110https://doaj.org/article/6978a6a1af86471db9fda97b11c647d12011-07-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21750674/pdf/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374HIV-1 infection is characterized by a chronic activation of the immune system and suppressed function of T lymphocytes. Regulatory CD4+ CD25(high) FoxP3+CD127(low) T cells (Treg) play a key role in both conditions. Here, we show that HIV-1 positive patients have a significant increase of Treg-associated expression of CD39/ENTPD1, an ectoenzyme which in concert with CD73 generates adenosine. We show in vitro that the CD39/adenosine axis is involved in Treg suppression in HIV infection. Treg inhibitory effects are relieved by CD39 down modulation and are reproduced by an adenosine-agonist in accordance with a higher expression of the adenosine A2A receptor on patients' T cells. Notably, the expansion of the Treg CD39+ correlates with the level of immune activation and lower CD4+ counts in HIV-1 infected patients. Finally, in a genetic association study performed in three different cohorts, we identified a CD39 gene polymorphism that was associated with down-modulated CD39 expression and a slower progression to AIDS.Maria NikolovaMatthieu CarriereMohammad-Ali JenabianSophie LimouMehwish YounasAyrin KökSophie HuëNabila SeddikiAnne HulinOlivier DelaneauHanneke SchuitemakerJoshua T HerbeckJames I MullinsMaria MuhtarovaArmand BensussanJean-François ZaguryJean-Daniel LelievreYves LévyPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 7, Iss 7, p e1002110 (2011)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Maria Nikolova
Matthieu Carriere
Mohammad-Ali Jenabian
Sophie Limou
Mehwish Younas
Ayrin Kök
Sophie Huë
Nabila Seddiki
Anne Hulin
Olivier Delaneau
Hanneke Schuitemaker
Joshua T Herbeck
James I Mullins
Maria Muhtarova
Armand Bensussan
Jean-François Zagury
Jean-Daniel Lelievre
Yves Lévy
CD39/adenosine pathway is involved in AIDS progression.
description HIV-1 infection is characterized by a chronic activation of the immune system and suppressed function of T lymphocytes. Regulatory CD4+ CD25(high) FoxP3+CD127(low) T cells (Treg) play a key role in both conditions. Here, we show that HIV-1 positive patients have a significant increase of Treg-associated expression of CD39/ENTPD1, an ectoenzyme which in concert with CD73 generates adenosine. We show in vitro that the CD39/adenosine axis is involved in Treg suppression in HIV infection. Treg inhibitory effects are relieved by CD39 down modulation and are reproduced by an adenosine-agonist in accordance with a higher expression of the adenosine A2A receptor on patients' T cells. Notably, the expansion of the Treg CD39+ correlates with the level of immune activation and lower CD4+ counts in HIV-1 infected patients. Finally, in a genetic association study performed in three different cohorts, we identified a CD39 gene polymorphism that was associated with down-modulated CD39 expression and a slower progression to AIDS.
format article
author Maria Nikolova
Matthieu Carriere
Mohammad-Ali Jenabian
Sophie Limou
Mehwish Younas
Ayrin Kök
Sophie Huë
Nabila Seddiki
Anne Hulin
Olivier Delaneau
Hanneke Schuitemaker
Joshua T Herbeck
James I Mullins
Maria Muhtarova
Armand Bensussan
Jean-François Zagury
Jean-Daniel Lelievre
Yves Lévy
author_facet Maria Nikolova
Matthieu Carriere
Mohammad-Ali Jenabian
Sophie Limou
Mehwish Younas
Ayrin Kök
Sophie Huë
Nabila Seddiki
Anne Hulin
Olivier Delaneau
Hanneke Schuitemaker
Joshua T Herbeck
James I Mullins
Maria Muhtarova
Armand Bensussan
Jean-François Zagury
Jean-Daniel Lelievre
Yves Lévy
author_sort Maria Nikolova
title CD39/adenosine pathway is involved in AIDS progression.
title_short CD39/adenosine pathway is involved in AIDS progression.
title_full CD39/adenosine pathway is involved in AIDS progression.
title_fullStr CD39/adenosine pathway is involved in AIDS progression.
title_full_unstemmed CD39/adenosine pathway is involved in AIDS progression.
title_sort cd39/adenosine pathway is involved in aids progression.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/6978a6a1af86471db9fda97b11c647d1
work_keys_str_mv AT marianikolova cd39adenosinepathwayisinvolvedinaidsprogression
AT matthieucarriere cd39adenosinepathwayisinvolvedinaidsprogression
AT mohammadalijenabian cd39adenosinepathwayisinvolvedinaidsprogression
AT sophielimou cd39adenosinepathwayisinvolvedinaidsprogression
AT mehwishyounas cd39adenosinepathwayisinvolvedinaidsprogression
AT ayrinkok cd39adenosinepathwayisinvolvedinaidsprogression
AT sophiehue cd39adenosinepathwayisinvolvedinaidsprogression
AT nabilaseddiki cd39adenosinepathwayisinvolvedinaidsprogression
AT annehulin cd39adenosinepathwayisinvolvedinaidsprogression
AT olivierdelaneau cd39adenosinepathwayisinvolvedinaidsprogression
AT hannekeschuitemaker cd39adenosinepathwayisinvolvedinaidsprogression
AT joshuatherbeck cd39adenosinepathwayisinvolvedinaidsprogression
AT jamesimullins cd39adenosinepathwayisinvolvedinaidsprogression
AT mariamuhtarova cd39adenosinepathwayisinvolvedinaidsprogression
AT armandbensussan cd39adenosinepathwayisinvolvedinaidsprogression
AT jeanfrancoiszagury cd39adenosinepathwayisinvolvedinaidsprogression
AT jeandaniellelievre cd39adenosinepathwayisinvolvedinaidsprogression
AT yveslevy cd39adenosinepathwayisinvolvedinaidsprogression
_version_ 1718424670919720960